We have an updated report [Version - 2023] available. Kindly sign up to get the sample of the report.
Healthcare and Pharmaceuticals industry

Global Molecular Imaging Market Size Share Forecast 2025




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Molecular imaging is a technique used to study cellular and molecular processes in order to detect and diagnose complex molecular mechanisms, molecular changes, and gene expression present in the course of the disease. Molecular imaging includes the field of nuclear medicine, which use traces of radioactive materials (radiopharmaceuticals) to diagnose and treat disease. Molecular imaging provide information that is unreachable with other imaging technologies or that would require more invasive procedures such as surgery or biopsy. Moreover, it identify disease in its initial stages and determine the exact location of a tumor, often before symptoms occur or abnormalities can be detected with other diagnostic tests.
Market Dynamics
Increasing prevalence of various chronic diseases such as cancer and other genetic disorders are propelling demand for early disease diagnosis eventually driving the medical imaging market growth. According to the Centers for Disease Control and Prevention (CDC), February 2018 data, in the U.S., around 22,000 men and 9,000 women suffer from liver cancer, and around 16,000 men and 8,000 women die from liver cancer annually. Molecular imaging has become part of standard care for many types of cancer. The use of imaging techniques in early cancer detection, treatment response, and new therapy development is steadily growing and has already significantly impacted on clinical management of cancer.
Moreover, rising cases of neurological disorders such as Alzheimer’s, which can be easily detected with PET-CT scanner is also contributing to the medical imaging market growth. For instance, according to the Alzheimer’s Association, in 2017, over 5 million people were estimated to be suffering from Alzheimer’s disease, which was also reported to be the sixth-leading cause of death in the U.S. However, some limitations associated with molecular modalities including side effects of radiation and lack of penetration depth, which is expected to confine the molecular imaging market growth to some extent.
Key features of the study:

This report provides in-depth analysis of the molecular imaging market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
It profiles key players in the global molecular imaging market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key players covered as a part of this study include Carestream Health, Fujifilm Holdings Corporation, GE Healthcare, Hitachi Ltd, Hologic, Inc., Siemens AG, Philips Healthcare, Samsung Medison, Shimadzu Corporation, and Toshiba Medical Systems Corporation.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
The global molecular imaging market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for molecular imaging market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Molecular Imaging Market, By Technology:

Gamma Camera
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging

Global Molecular Imaging Market, By Application:

Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others

Global Molecular Imaging Market, By End User:

Hospitals
Diagnostic Imaging Centers
Others

Global Molecular Imaging Market, By Region:

North America

By Country:

U.S.
Canada

By Technology:

Gamma Camera
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging

By Application:

Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others

By End Use:

Hospitals
Diagnostic Imaging Centers
Others


Europe

By Country:

U.K.
Germany
Italy
Spain
France
Russia
Rest of Europe

By Technology:

Gamma Camera
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging

By Application:

Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others

By End Use:

Hospitals
Diagnostic Imaging Centers
Others


Asia Pacific

By Country:

Australia
India
China
Japan
ASEAN
South Korea
Rest of Asia Pacific

By Technology:

Gamma Camera
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging

By Application:

Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others

By End Use:

Hospitals
Diagnostic Imaging Centers
Others


Latin America

By Country:

Brazil
Mexico
Argentina
Rest of Latin America

By Technology:

Gamma Camera
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging

By Application:

Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others

By End Use:

Hospitals
Diagnostic Imaging Centers
Others


Middle East

By Country:

GCC
Israel
Rest of Middle East

By Technology:

Gamma Camera
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging

By Application:

Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others

By End Use:

Hospitals
Diagnostic Imaging Centers
Others


Africa

By Country:

South Africa
Central Africa
North Africa

By Technology:

Gamma Camera
Single Photon Emission Computed Tomography (SPECT)
Positron Emission Tomography (PET)
Magnetic Resonance Spectroscopy
Optical Imaging
Molecular Ultrasound Imaging

By Application:

Cancer
Heart Disease
Brain Disorder
Gastrointestinal Disorder
Lung Disorder
Bone Disorder
Others

By End Use:

Hospitals
Diagnostic Imaging Centers
Others



Company Profiles

Carestream Health*

Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies

Fujifilm Holdings Corporation
GE Healthcare
Hitachi Ltd
Hologic, Inc.
Siemens AG
Philips Healthcare
Samsung Medison
Shimadzu Corporation
Toshiba Medical Systems Corporation


“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
o Market Definition and Scope
o Executive Summary
o Market Snippet, By Technology
o Market Snippet, By Application
o Market Snippet, By End User
o Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
o Drivers
o Restraints
o Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Recalls
o Reimbursement
o Technology Advancements
o Value Chain Analysis
o Regulatory Landscape
o Major Brand Analysis
o PEST Analysis
o Porter's Five Forces
4. Global Molecular imaging Market, By Technology, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Gamma Camera
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Single Photon Emission Computed Tomography (SPECT)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Positron Emission Tomography (PET)
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Magnetic Resonance Spectroscopy
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Optical Imaging
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Molecular Ultrasound Imaging
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
5. Global Molecular imaging Market, By Application, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Cancer
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Heart Disease
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Brain Disorder
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Gastrointestinal Disorder
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Lung Disorder
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Bone Disorder
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
6. Global Molecular imaging Market, By End User, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, 2017 - 2026
o Segment Trends
o Hospitals
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Diagnostic Imaging Centers
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
o Others
o Introduction
o Market Size and Forecast, and Y-o-Y Growth, 2016 - 2026, (US$ Million)
7. Global Molecular imaging Market, By Region, 2018 - 2026, (US$ Million)
o Introduction
o Market Share Analysis, By Region, 2018 and 2026 (%)
o Y-o-Y Growth Analysis, By Region, 2016 - 2026
o Regional Trends
o North America
o Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.S.
o Canada
o Europe
o Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
o Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o China
o Japan
o India
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Latin America
o Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
o Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o Northern Africa
o Central Africa
o South Africa
o Middle East
o Market Size and Forecast, By Technology, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Application, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By End User, 2016 - 2026, (US$ Million)
o Market Size and Forecast, By Country, 2016 - 2026, (US$ Million)
o GCC Countries
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
o Carestream Health
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Fujifilm Holdings Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o GE Healthcare
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Hitachi Ltd
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Hologic, Inc.
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Siemens AG
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Philips Healthcare
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Samsung Medison
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Shimadzu Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Toshiba Medical Systems Corporation
o Company Overview
o Product Portfolio
o Financial Performance
o Recent Highlights
o Strategies
o Analyst Views
9. Section
o References
o Research Methodology
o About Us and Sales Contact
*Browse 27 market data tables and 31 figures on "Molecular Imaging Market" - Global forecast to 2026".

 



Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.